Basit öğe kaydını göster

PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE

dc.contributor.authorKlatte, Tobias
dc.contributor.authorErdem, Selçuk
dc.contributor.authorRubio-Briones, Jose
dc.contributor.authorHeck, Matthias
dc.contributor.authorPorpiglia, Francesco
dc.contributor.authorCheccucci, Enrico
dc.contributor.authorVan Bruwaene, Siska
dc.contributor.authorLinares, Estefania
dc.contributor.authorHevia, Vital
dc.contributor.authorMusquera, Mireia
dc.contributor.authorMusquera, Mireia
dc.contributor.authorD'anna, Mauricio
dc.contributor.authorDerweesh, Ithaar
dc.contributor.authorMeagher, Margaret F.
dc.contributor.authorGhali, Fadi
dc.contributor.authorAutorino, Riccardo
dc.contributor.authorVecchia, Alessandro
dc.contributor.authorGuruli, Georgi
dc.contributor.authorPavan, Nicola
dc.contributor.authorClaps, Francesco
dc.contributor.authorAntonelli, Alessandro
dc.contributor.authorPalumbo, Carlotta
dc.contributor.authorAntonelli, Alessandro
dc.contributor.authorCarmen Mir, M.
dc.contributor.authorMarchioni, Michele
dc.contributor.authorCampi, Riccardo
dc.contributor.authorMinervini, Andrea
dc.contributor.authorRoussel, Eduard
dc.contributor.authorAlbertsen, Maarteen
dc.contributor.authorCapitanio, Umberto
dc.contributor.authorMaximilian, Kriegmair
dc.date.accessioned2021-03-02T19:14:16Z
dc.date.available2021-03-02T19:14:16Z
dc.identifier.citationCarmen Mir M., Marchioni M., Campi R., Minervini A., Roussel E., Albertsen M., Capitanio U., Klatte T., Maximilian K., Erdem S., et al., "PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE", Annual Meeting of the American-Urological-Association (AUA), Washington, Kiribati, 15 - 18 Mayıs 2020, cilt.203
dc.identifier.othervv_1032021
dc.identifier.otherav_e09d7718-c700-464b-9ef6-653cef6f461c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/5386
dc.language.isoeng
dc.subjectNefroloji
dc.subjectSağlık Bilimleri
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.titlePERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume203
dc.contributor.firstauthorID2371271


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster